Sarcopenic Obesity: Estimation of Prevalence and Identification of Clinical and Biological Determinants in a Population of Adult Obese Patients

What this study involves

The registry does not currently label this study as recruiting. Ask about its status before planning a screening visit.

Study type

Interventional

Phase

Not applicable

Age range

18 years - 70 years

Sex eligible

All sexes

Healthy volunteers

Not accepted

Participants

799 Actual

These are starting points, not an eligibility decision. The research team must review the full requirements.

About the research

This project aims first to determine the prevalence of sarcopenia in a population of obese people of extended age group (18-70 years). In a second step, the factors determining and / or predisposing to sarcopenic obesity will be identified as well as plasmatic and urinary biomarkers specific to this phenotype.

Who may be able to participate?

The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.

Inclusion Criteria:

• Age: 18-70 years
• Sex: men and women
• Patient followed in clinical nutrition benefiting from a metabolic assessment for optimization of clinical and paraclinical management
• Patient meeting the criteria of obesity defined by BMI\> 30 kg / m²
• Major patient with free, informed and signed consent
• Patient covered by the social security scheme

Exclusion Criteria:

• Patient with cancer or severe chronic disease (renal failure, respiratory failure, liver failure)
• Patient with neuromuscular disease
• Patient with a total inability to walk
• Minor patient
• Refusal of the patient to participate in the study
• Pregnant or lactating women
• Patient deprived of liberty or under guardianship.

Treatment, groups and participation

The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.

Assignment

Not applicable

Masking

No masking

What researchers are measuring

Outcome measures describe what is being studied. They are not proof that a treatment works.

Primary measures

Research locations (1)

The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.

1 locations

Study team and timeline

Lead sponsor

University Hospital, Clermont-Ferrand

Study start

Jun 4, 2018 Actual

Primary completion

Apr 8, 2022 Actual

Study completion

Apr 8, 2022 Actual

First posted

Jan 9, 2018 Actual

Last updated

Nov 10, 2026 Actual

Official study contacts

No central contact is listed. Check the locations and the official record.